Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.

Tomescu-Baciu A, Johansen JN, Holmøy T, Greiff V, Stensland M, de Souza GA, Vartdal F, Lossius A.

J Neuroimmunol. 2019 Aug 15;333:576966. doi: 10.1016/j.jneuroim.2019.576966. Epub 2019 May 16.

PMID:
31153015
2.

G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis.

Tomescu-Baciu A, Vartdal F, Holmøy T, Vedeler CA, Lossius A.

Ann Clin Transl Neurol. 2018 Sep 17;5(10):1303-1309. doi: 10.1002/acn3.642. eCollection 2018 Oct.

3.

B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate.

Høglund RA, Polak J, Vartdal F, Holmøy T, Lossius A.

Mult Scler Relat Disord. 2018 Nov;26:90-95. doi: 10.1016/j.msard.2018.08.032. Epub 2018 Sep 6.

PMID:
30243235
4.

Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis.

Lossius A, Tomescu-Baciu A, Holmøy T, Vedeler CA, Røsjø E, Lorentzen ÅR, Casetta I, Vartdal F.

Ann Clin Transl Neurol. 2017 Sep 27;4(10):756-761. doi: 10.1002/acn3.451. eCollection 2017 Oct.

5.

High-throughput sequencing of immune repertoires in multiple sclerosis.

Lossius A, Johansen JN, Vartdal F, Holmøy T.

Ann Clin Transl Neurol. 2016 Feb 25;3(4):295-306. doi: 10.1002/acn3.295. eCollection 2016 Apr. Review.

6.

Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome.

Johansen JN, Vartdal F, Desmarais C, Tutturen AE, de Souza GA, Lossius A, Holmøy T.

Clin Immunol. 2015 Oct;160(2):211-25. doi: 10.1016/j.clim.2015.06.001. Epub 2015 Jun 6.

PMID:
26055752
7.

High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.

Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J.

Eur J Immunol. 2014 Nov;44(11):3439-52. doi: 10.1002/eji.201444662. Epub 2014 Sep 16.

8.

[In accordance with the law].

Vartdal F.

Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):267. doi: 10.4045/tidsskr.14.0078. Norwegian. No abstract available.

9.

Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmøy T.

Viruses. 2012 Dec;4(12):3701-30. Review.

10.

Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis.

Lossius A, Vartdal F, Holmøy T.

J Neuroimmunol. 2011 Dec 15;240-241:87-96. doi: 10.1016/j.jneuroim.2011.09.011. Epub 2011 Oct 22.

PMID:
22018702
11.

[Leadership and academic competence].

Smeland EB, Vartdal F, Wisløff F.

Tidsskr Nor Laegeforen. 2010 Mar 25;130(6):591. doi: 10.4045/tidsskr.10.0217. Norwegian. No abstract available.

12.

[Close cooperation, but not oversteering].

Smeland EB, Vartdal F, Wisløff F.

Tidsskr Nor Laegeforen. 2010 Mar 25;130(6):590-1. doi: 10.4045/tidsskr.10.0153. Norwegian. No abstract available.

13.

The idiotype connection: linking infection and multiple sclerosis.

Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B.

Trends Immunol. 2010 Feb;31(2):56-62. doi: 10.1016/j.it.2009.11.001. Epub 2009 Dec 2.

PMID:
19962346
14.

Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update.

Holmøy T, Harbo H, Vartdal F, Spurkland A.

Curr Mol Med. 2009 Jun;9(5):591-611. Review.

PMID:
19601809
15.

Protective and detrimental immunity: lessons from stiff person syndrome and multiple sclerosis.

Holmøy T, Skorstad G, Hestvik AL, Alvik KM, Vartdal F.

Acta Neurol Scand Suppl. 2009;(189):22-6. doi: 10.1111/j.1600-0404.2009.01207.x.

PMID:
19566493
16.

MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro.

Skorstad G, Vandvik B, Vartdal F, Holmøy T.

Eur J Neurol. 2009 Oct;16(10):1124-9. doi: 10.1111/j.1468-1331.2009.02657.x. Epub 2009 May 14.

PMID:
19469834
17.

Idiotope-specific CD4(+) T cells induce apoptosis of human oligodendrocytes.

Hestvik AL, Skorstad G, Vartdal F, Holmøy T.

J Autoimmun. 2009 Mar;32(2):125-32. doi: 10.1016/j.jaut.2009.01.004. Epub 2009 Feb 27.

PMID:
19250800
18.

Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome.

Skorstad G, Hestvik AL, Vartdal F, Holmøy T.

J Autoimmun. 2009 Feb;32(1):24-32. doi: 10.1016/j.jaut.2008.10.002. Epub 2008 Nov 21.

PMID:
19027267
19.

GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.

Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, Holmøy T.

Eur J Neurol. 2008 Sep;15(9):973-80. doi: 10.1111/j.1468-1331.2008.02221.x. Epub 2008 Jul 10.

PMID:
18637036
20.

Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid.

Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T.

Mult Scler. 2008 Jul;14(6):749-58. doi: 10.1177/1352458508089411.

PMID:
18611988
21.

The SH2D2A gene and susceptibility to multiple sclerosis.

Lorentzen AR, Smestad C, Lie BA, Oturai AB, Akesson E, Saarela J, Myhr KM, Vartdal F, Celius EG, Sørensen PS, Hillert J, Spurkland A, Harbo HF.

J Neuroimmunol. 2008 Jul 15;197(2):152-8. doi: 10.1016/j.jneuroim.2008.04.037. Epub 2008 Jun 12.

PMID:
18554728
22.

T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG.

Hestvik AL, Vartdal F, Fredriksen AB, Thompson KM, Kvale EO, Skorstad G, Bogen B, Holmoy T.

Scand J Immunol. 2007 Oct;66(4):393-401.

23.

The immunological basis for treatment of multiple sclerosis.

Holmøy T, Vartdal F.

Scand J Immunol. 2007 Oct;66(4):374-82. Review.

24.

Management of progressive multifocal leukoencephalopathy associated with natalizumab--possibilities and responsibility.

Holmøy T, Hestvik AL, Vartdal F.

Eur J Neurol. 2006 Aug;13(8):e2. No abstract available.

PMID:
16879280
25.

Towards individualised multiple sclerosis treatment.

Holmøy T, Hestvik AL, Vartdal F.

Lancet Neurol. 2006 Feb;5(2):111-2. No abstract available.

PMID:
16426986
26.

Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.

Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF.

J Neuroimmunol. 2005 Sep;166(1-2):197-201.

PMID:
16005527
27.
28.

Infectious causes of multiple sclerosis.

Holmøy T, Vartdal F.

Lancet Neurol. 2005 May;4(5):268; discussion 269. No abstract available.

PMID:
15847838
29.
30.

Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5'-monophosphate-responsive element in the proximal SH2D2A promoter.

Dai KZ, Johansen FE, Kolltveit KM, Aasheim HC, Dembic Z, Vartdal F, Spurkland A.

J Immunol. 2004 May 15;172(10):6144-51.

31.

Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.

Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sørensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A.

Tissue Antigens. 2004 Mar;63(3):237-47.

PMID:
14989713
32.
33.

Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients.

Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, Compston A, Vartdal F, Spurkland A.

J Neuroimmunol. 2003 Oct;143(1-2):101-6.

PMID:
14575924
34.

MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.

Gregers TF, Fleckenstein B, Vartdal F, Roepstorff P, Bakke O, Sandlie I.

Int Immunol. 2003 Nov;15(11):1291-9.

PMID:
14565927
35.

Physical separation of HLA-A alleles by denaturing high-performance liquid chromatography.

Etokebe GE, Opsahl M, Tveter AK, Lie BA, Thorsby E, Vartdal F, Spurkland A.

Tissue Antigens. 2003 Jun;61(6):443-50.

PMID:
12823768
36.

T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.

Holmøy T, Vandvik B, Vartdal F.

Mult Scler. 2003 Jun;9(3):228-34.

PMID:
12814167
37.

Genetic background for immune-mediated diseases.

Vartdal F.

Acta Odontol Scand. 2001 Aug;59(4):212-5. Review.

PMID:
11570523
38.

The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis.

Dai KZ, Harbo HF, Celius EG, Oturai A, Sørensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A.

Genes Immun. 2001 Aug;2(5):263-8.

39.

No linkage or association of the nitric oxide synthase genes to multiple sclerosis.

Modin H, Dai Y, Masterman T, Svejgaard A, Sørensen PS, Oturai A, Ryder LP, Spurkland A, Vartdal F, Laaksonen M, Sandberg-Wollheim M, Myhr KM, Nyland H, Hillert J.

J Neuroimmunol. 2001 Sep 3;119(1):95-100.

PMID:
11525805
40.

The role of HLA matching in renal transplantation: experience from one center.

Leivestad T, Reisaeter AV, Brekke IB, Vartdal F, Thorsby E.

Rev Immunogenet. 1999;1(3):343-50.

PMID:
11256425
41.

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis.

Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A.

J Neurol Sci. 2000 Sep 15;178(2):132-5.

PMID:
11018705
42.

[Immunologic reactions in transplantation].

Vartdal F, Thorsby E.

Tidsskr Nor Laegeforen. 1999 Sep 10;119(21):3167-70. Review. Norwegian.

PMID:
10522486
43.

CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.

Harbo HF, Celius EG, Vartdal F, Spurkland A.

Tissue Antigens. 1999 Jan;53(1):106-10.

PMID:
10082437
44.

Transplantation immunology--the role of human leucocyte antigen in allorecognition.

Vartdal F, Thorsby E.

Curr Top Pathol. 1999;92:1-18. Review. No abstract available.

PMID:
9919804
45.

[The medical prize of Anders Jahre 1998].

Fossum S, Vartdal F.

Ugeskr Laeger. 1998 Dec 21;160(52):7620-1. Danish. No abstract available.

PMID:
9889687
46.

A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients.

Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E.

Transplantation. 1998 Aug 27;66(4):523-8.

PMID:
9734498
47.

Erik Thorsby is 60.

Vartdal F.

Tissue Antigens. 1998 Jul;52(1):96-8. No abstract available.

PMID:
9714483
48.

A peptide-binding assay for the disease-associated HLA-DQ8 molecule.

Straumfors A, Johansen BH, Vartdal F, Sollid LM, Thorsby E, Buus S.

Scand J Immunol. 1998 Jun;47(6):561-7.

49.

Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites.

Spurkland A, Brinchmann JE, Markussen G, Pedeutour F, Munthe E, Lea T, Vartdal F, Aasheim HC.

J Biol Chem. 1998 Feb 20;273(8):4539-46.

50.

Supplemental Content

Loading ...
Support Center